Finance
Constellium SE (NYSE: CSTM) announced today that the Board of Directors has authorized a new share repurchase program of up to $300 million of the Company's outstanding ordinary shares, which will become effective following the Company’s 2026 Annual General Meeting of Shareholders to be held on May 21, 2026, and will expire on December 31, 2028. The new share repurchase program will replace the current share repurchase program authorized by the Board of Directors in February 2024, and the Company retains the ability to repurchase shares under the current program until the new program takes effect.
“I am excited to announce today that our Board has authorized a new share repurchase program of up to $300 million,” said Ingrid Joerg, Constellium’s Chief Executive Officer. “This new program will replace the existing program and allow us to continue returning capital to our shareholders as part of our balanced capital allocation strategy.”
Under this new share repurchase program, the Company will be able to repurchase its own shares from time to time for cash in open market transactions or in privately-negotiated transactions, in accordance with applicable state and federal securities laws and in compliance with applicable provisions of French corporate law, and it will be able to make all or part of the purchases pursuant to Rule 10b5-1 plans. The timing and the amount of repurchases, if any, will be determined based on the Company's evaluation of market conditions, capital allocation alternatives and other factors. The share repurchase program does not require the Company to acquire any dollar amount or number of Constellium’s ordinary shares and may be modified, suspended, extended or terminated by the Company's Board of Directors at any time without prior notice. To be able to execute the share repurchase program in full, the Company will continue to seek shareholder approval each year at its Annual General Meetings.